Delivery Order SPE2DE24D0013-SPE2D625F0LHB
- Not listed
- The U.S. Defense Department's Medical Supply Chain division awarded a $23,475.80 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. The contract, designated XPCOV2/FLU/RSV-10, was awarded on July 29, 2025, with an ultimate completion date of August 12, 2025, and carries no set-aside designation. Work will be performed at Cepheid's Sunnyvale facility. This delivery order represents procurement of diagnostic testing...
- The Defense Department's Medical Supply Chain division awarded Cepheid Inc. a $17,952 firm fixed-price delivery order on August 4, 2025, for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. The contract is set to be completed by August 18, 2025, with performance taking place at Cepheid's headquarters in Sunnyvale, California. This delivery order represents a continuation of the Defense Department's reliance on Cepheid's GeneXpert...
- Cepheid has been awarded a delivery order valued at $7,276 under contract number 4568920470 for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. This firm fixed-price delivery order, issued by the Medical Supply Chain division of the Department of Defense, will be performed in Sunnyvale, California, with an ultimate completion date of August 11, 2025. The contract carries no set-aside designation and represents a continuation of...
- The Defense Department's Medical Supply Chain awarded a $4,080 firm fixed-price delivery order to Cepheid Inc. on July 18, 2025, for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. The contract, designated as XPCOV2/FLU/RSV-10, represents a delivery order with an ultimate completion date of July 25, 2025, and carries no set-aside designation. Work will be performed at Cepheid's facility in Sunnyvale, California. This award reflects...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $3,400 by the Defense Logistics Agency (a component of the Department of Defense) on August 4, 2025, with a completion date of August 11, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, involves firm fixed-price procurement of diagnostic testing solutions, specifically for COVID-19, influenza, and respiratory syncytial virus (RSV) detection capabilities. This...
- Cepheid, a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a firm fixed-price delivery order valued at $14,960 by the Defense Department's Medical Supply Chain on August 7, 2025, with an ultimate completion date of August 21, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, procures diagnostic testing solutions, specifically molecular reagents and assays for COVID-19, influenza, and respiratory syncytial virus (RSV) detection. This award carries...
- The U.S. Department of Defense awarded a $2,040 firm fixed-price delivery order to Cepheid Inc. on August 5, 2025, under contract number 4569009257 for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus testing. The contract, which carries no set-aside designation, is set to conclude by August 12, 2025, with performance taking place at Cepheid's headquarters in Sunnyvale, California. This delivery order falls under one of Cepheid's two significant...
- The U.S. Defense Department's Medical Supply Chain organization awarded Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, a $4,108.25 firm fixed-price delivery order (Contract No. 4569031063) on August 7, 2025, with completion scheduled for August 14, 2025. This delivery order carries no set-aside designation and represents a procurement of diagnostic solutions from Cepheid's established product portfolio. The award leverages Cepheid's expertise in molecular...
- The Defense Logistics Agency awarded a $12,240 firm fixed-price delivery order to Cepheid Inc. for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. The contract, with an ultimate completion date of August 15, 2025, was awarded on August 8, 2025, with no set-aside designation. Cepheid, a Sunnyvale, California-based manufacturer specializing in molecular diagnostic systems and test kits, will perform the work at its California...
- The U.S. Defense Logistics Agency, operating under the Medical Supply Chain office, awarded a firm fixed-price delivery order valued at $8,840 to Cepheid Inc. on July 29, 2025, with an ultimate completion date of August 5, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic testing solutions, specifically reagents and test kits for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). The contract carries no set-aside designation and will be...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F0LHBDelivery Order
The U.S. Department of Defense Medical Supply Chain awarded a $13,600 firm fixed-price delivery order to Cepheid Inc. for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. This delivery order, issued on August 7, 2025, with an ultimate completion date of August 14, 2025, represents a continuation of Cepheid's established role as a primary supplier of advanced diagnostic systems and test kits to federal healthcare entities. The contract carries no set-aside designation and is performed at Cepheid's headquarters in Sunnyvale, California. This award is associated with Cepheid's broader federal contracting portfolio, which includes two significant Indefinite Delivery Vehicles with the Department of Veterans Affairs valued at approximately $35.3 million. Cepheid specializes in GeneXpert diagnostic systems and related molecular reagents, providing comprehensive testing capabilities for infectious diseases across multiple federal agencies, including the VA, Indian Health Service, and Defense Logistics Agency. The company's consistent delivery of diagnostic equipment, reagents, and maintenance services positions it as a critical supplier within the federal healthcare supply chain for rapid point-of-care molecular testing.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.6k | 8/7/25 |